Genelux Management
Management criteria checks 1/4
Genelux's CEO is Tom Zindrick, appointed in May 2014, has a tenure of 10.5 years. total yearly compensation is $6.20M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 0.73% of the company’s shares, worth $638.03K. The average tenure of the management team and the board of directors is 1.3 years and 7 years respectively.
Key information
Tom Zindrick
Chief executive officer
US$6.2m
Total compensation
| CEO salary percentage | 9.2% |
| CEO tenure | 10.5yrs |
| CEO ownership | 0.7% |
| Management average tenure | 1.3yrs |
| Board average tenure | 7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$27m |
| Mar 31 2024 | n/a | n/a | -US$26m |
| Dec 31 2023 | US$6m | US$571k | -US$28m |
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$15m |
| Mar 31 2023 | n/a | n/a | -US$12m |
| Dec 31 2022 | US$500k | US$500k | -US$5m |
| Sep 30 2022 | n/a | n/a | -US$5m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | -US$17m |
| Dec 31 2021 | US$517k | US$500k | -US$16m |
| Mar 31 2021 | n/a | n/a | -US$13m |
| Dec 31 2020 | US$2m | US$519k | -US$14m |
Compensation vs Market: Tom's total compensation ($USD6.20M) is above average for companies of similar size in the US market ($USD650.80K).
Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.
CEO
Tom Zindrick (65 yo)
10.5yrs
Tenure
US$6,201,963
Compensation
Mr. Thomas Zindrick, also known as Tom, J.D., has been the Chief Executive Officer, Chief Compliance Officer and President at Genelux Corporation since May 2014. Mr. Zindrick has been Executive Chairman at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 10.5yrs | US$6.20m | 0.73% $ 638.0k | |
| Chief Financial Officer | 1.3yrs | US$3.06m | 0.11% $ 98.0k | |
| Chief Technical Officer | 1.3yrs | US$213.08k | 0.061% $ 53.4k | |
| General Counsel & Corporate Secretary | 3.1yrs | US$380.00k | 0.057% $ 49.4k | |
| Senior Vice President of Clinical Development | 1.3yrs | US$242.62k | 0.032% $ 27.7k | |
| Chief Medical Officer | 13.2yrs | no data | 0% $ 0 | |
| VP & Head of Regulatory Affairs | 1.3yrs | no data | 0.024% $ 20.8k |
1.3yrs
Average Tenure
65yo
Average Age
Experienced Management: GNLX's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 10.5yrs | US$6.20m | 0.73% $ 638.0k | |
| Lead Independent Director | 12.5yrs | US$284.13k | 0.028% $ 24.8k | |
| Non-Employee Independent Director | 22.2yrs | US$278.13k | 1.37% $ 1.2m | |
| Member of Clinical Advisory Board | 1.8yrs | no data | no data | |
| Independent Director | 1.2yrs | US$328.62k | 0.024% $ 20.8k | |
| Non-Employee Independent Director | 3.4yrs | US$222.07k | 0.037% $ 31.8k | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data |
7.0yrs
Average Tenure
66.5yo
Average Age
Experienced Board: GNLX's board of directors are considered experienced (7 years average tenure).